Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosaprepitant dimeglumine vs aprepitant for prevention of CINV with highly emetogenic chemotherapy
CTR20140900Phase 2Completed
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fosaprepitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Nov 2015; status: completed.
02
Drugs
fosaprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on CTR20140900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140900.